Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, January 31, 2015
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
New Metabolic Biomarkers Predict Future Cardiovascular Diseases
Scientists of the Helmholtz Zentrum München contributed to the analysis of the biomarkers.
New Cancer-Fighting Strategy Would Harden Cells to Prevent Metastasis
Potential drug for pancreatic cancer now being tested in animals.
Breakthrough Made On New Anesthetics
Over 350,000 compounds were tested for their potential as anesthetics.
Software Created to Help Find a Cure for a "Great Neglected Disease"
SF State-led team's software determines drugs' effectiveness in treating schistosomiasis.
A Standard for Neuroscience Data
Berkeley Lab researchers have developed a computational framework for standardizing neuroscience data worldwide.
Project to Focus on Link Between Immune System and Brain Disorders
Researchers to investigate whether mood disorders, such as depression, and neurodegenerative diseases, such as Alzheimer’s, could be treated by targeting the immune system.
53 Approved Drugs that May Block Ebola Infection Identified
Compounds may keep virus from entering cells and could accelerate drug development.
New Research Unlocks a Mystery of Albinism
A team led by Brown University biologists has discovered the way in which a specific genetic mutation appears to lead to the lack of melanin production underlying a form of albinism.
Biomarker Discovery Sheds New Light on Heart Attack Risk of Arthritis Drugs
Drug may be given a new lease of life.
New Way To Turn Genes On
Technique allows rapid, large-scale studies of gene function.
Scroll Up
Scroll Down
Return
Chemical Probe Discovery in the Academic Sector Through the NIH Roadmap Molecular Libraries Program from the Pilot to Production Phase
Thomas Chung, Project Manager, Conrad Prebys Center for Chemical Genomics, Burnham Institute for Medical Research, speaking at Probe Discovery 2009
Date Posted: Sunday, August 15, 2010
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Burnham Announces License Agreement with Johnson & Johnson Pharmaceutical Research & Development
Burnham to provide J&JPRD with access to high-throughput assay screening technologies to investigate certain drug targets for inflammatory diseases.
Wednesday, January 14, 2009
 
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn